Suppr超能文献

越南、柬埔寨、新加坡和菲律宾2016 - 2018年抗生素耐药性调查(SOAR)结果:基于临床和实验室标准协会(CLSI)、欧洲药敏试验委员会(EUCAST,剂量特异性)以及药代动力学/药效学(PK/PD)断点的数据

Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

作者信息

Torumkuney D, Van P H, Thinh L Q, Koo S H, Tan S H, Lim P Q, Sivhour C, Lamleav L, Somary N, Sosorphea S, Lagamayo E, Morrissey I

机构信息

GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.

Nguyen Tri Phuong Hospital, Ho Chi Minh City, Vietnam.

出版信息

J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i19-i42. doi: 10.1093/jac/dkaa082.

Abstract

OBJECTIVES

To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates collected from community-acquired respiratory tract infections (CA-RTIs) in 2016-18 in four Asian countries.

METHODS

MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

RESULTS

In total, 260 S. pneumoniae and 258 H. influenzae isolates were tested. Pneumococci from Vietnam (n = 161) were the least susceptible, with rates of susceptibility >90% for fluoroquinolones by CLSI breakpoints, ∼60% for amoxicillin, amoxicillin/clavulanic acid and ceftriaxone but <14% for most other agents. Pneumococcal isolates from Cambodia (n = 48) and Singapore (n = 34) showed susceptibilities ranging from ∼30% for trimethoprim/sulfamethoxazole and oral penicillin to 100% for fluoroquinolones. Among isolates of H. influenzae from Cambodia (n = 30), the Philippines (n = 59) and Singapore (n = 80), rates of susceptibility using CLSI breakpoints were >90% for amoxicillin/clavulanic acid, cephalosporins [except cefaclor in Singapore (77.5%)], macrolides and fluoroquinolones; for isolates from Vietnam (n = 89) the rates of susceptibility were >85% only for amoxicillin/clavulanic acid (95.5%), ceftriaxone (100%) and macrolides (87.6%-89.9%). Susceptibility to other antibiotics ranged from 7.9% (trimethoprim/sulfamethoxazole) to 57.3%-59.6% (fluoroquinolones) and 70.8% (cefixime). The application of different EUCAST breakpoints for low and higher doses for some of the antibiotics (amoxicillin, amoxicillin/clavulanic acid, ampicillin, penicillin, ceftriaxone, clarithromycin, erythromycin, levofloxacin and trimethoprim/sulfamethoxazole) allowed, for the first time in a SOAR study, the effect of raising the dosage on susceptibility to be quantified. A limitation of the study was the small sample sizes and only one or two sites participating per country; however, since susceptibility data are scarce in some of the participating countries any information concerning antibiotic susceptibility is of value.

CONCLUSIONS

Antibiotic susceptibility varied across countries and species, with isolates from Vietnam demonstrating the lowest susceptibility. Knowledge of resistance patterns can be helpful for clinicians when choosing empirical therapy options for CA-RTIs.

摘要

目的

确定2016 - 2018年在四个亚洲国家从社区获得性呼吸道感染(CA-RTIs)中分离出的肺炎链球菌和流感嗜血杆菌的抗生素敏感性。

方法

采用CLSI肉汤微量稀释法测定最低抑菌浓度(MICs),并使用CLSI、EUCAST(剂量特异性)和药代动力学/药效学(PK/PD)断点评估敏感性。

结果

总共检测了260株肺炎链球菌和258株流感嗜血杆菌。来自越南的肺炎球菌(n = 161)最不敏感,按照CLSI断点,氟喹诺酮类药物的敏感率>90%,阿莫西林、阿莫西林/克拉维酸和头孢曲松的敏感率约为60%,但大多数其他药物的敏感率<14%。来自柬埔寨(n = 48)和新加坡(n = 34)的肺炎球菌分离株对甲氧苄啶/磺胺甲恶唑和口服青霉素的敏感率约为30%,对氟喹诺酮类药物的敏感率为100%。在来自柬埔寨(n = 30)、菲律宾(n = 59)和新加坡(n = 80)的流感嗜血杆菌分离株中,按照CLSI断点,阿莫西林/克拉维酸、头孢菌素[新加坡的头孢克洛除外(77.5%)]、大环内酯类和氟喹诺酮类药物的敏感率>90%;对于来自越南(n = 89)的分离株,仅阿莫西林/克拉维酸(95.5%)、头孢曲松(100%)和大环内酯类(87.6% - 89.9%)的敏感率>85%。对其他抗生素的敏感率范围为7.9%(甲氧苄啶/磺胺甲恶唑)至57.3% - 59.6%(氟喹诺酮类)和70.8%(头孢克肟)。对于某些抗生素(阿莫西林、阿莫西林/克拉维酸、氨苄西林、青霉素、头孢曲松、克拉霉素、红霉素、左氧氟沙星和甲氧苄啶/磺胺甲恶唑),应用不同的EUCAST低剂量和高剂量断点,在一项SOAR研究中首次能够量化提高剂量对敏感性的影响。该研究的一个局限性是样本量小且每个国家只有一两个地点参与;然而,由于一些参与国家的敏感性数据稀缺,任何有关抗生素敏感性的信息都有价值。

结论

抗生素敏感性因国家和菌种而异,来自越南的数据显示敏感性最低。了解耐药模式有助于临床医生为CA-RTIs选择经验性治疗方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验